Sveriges mest populära poddar
EP Edge Journal Watch: Cardiac Electrophysiology Research
EP Edge Journal Watch: Cardiac Electrophysiology Research

EP Edge® Journal Watch 44, November 2026: AF Ablation Endpoints, Conduction System Pacing and Exercise

28 min•9 november 2026

Om avsnittet

EP Edge® Journal Watch 44, November 2026: AF Ablation Endpoints, Conduction System Pacing and Exercise

What should count as successful atrial fibrillation ablation? Can shorter follow-up reliably assess treatment effectiveness? How might conduction system pacing, atrial physiology, and exercise intensity influence the way we evaluate and manage arrhythmia risk?

In Issue 44 of EP Edge® Journal Watch, Dr. Sharma examines five featured publications in depth, explaining their rationale, methods, findings, statistical interpretation, limitations, and practical implications. The episode also provides brief assessments of the remaining publications, with comprehensive analyses and infographics available in the newsletter.

Designed for electrophysiologists, cardiologists, trainees, and clinicians interested in cardiovascular research, this episode connects the evidence to the decisions it can reasonably inform.

FEATURED DISCUSSIONS

AF ablation endpoints: why six minutes, and why two months of blanking?

Wang and colleagues’ Academic Research Consortium report proposes a framework for evaluating atrial fibrillation ablation effectiveness and safety. We examine the rationale behind the six-minute recurrence threshold, the two-month blanking period, and the distinction between device detection and adjudicated trial outcomes. The discussion also covers AF burden, medication exposure, monitoring intensity, follow-up duration, and safety assessment for emerging technologies.

Wang PJ, et al. Atrial Fibrillation Ablation Effectiveness End Points, Safety End Points, and Trial Design: Academic Research Consortium Initiative Endorsed by the Heart Rhythm Society. Circulation: Arrhythmia and Electrophysiology. 2026.

DOI: https://doi.org/10.1161/CIRCEP.126.015082

Can six-month outcomes predict twelve-month ablation success?

Andrade and colleagues analyze 905 patients from four prospective studies. Agreement between shorter and conventional endpoints was high, but sensitivity for identifying conventional failures ranged from 57% to 76%. We explain why accurate population estimates do not necessarily mean accurate individual classification, and distinguish this six-month total assessment from the consortium’s eight-month recommendation for established technologies in paroxysmal AF.

Andrade JG, et al. Incorporating a Shortened Long-Term Effectiveness End Point Into Catheter Ablation Trials: Statistical Properties and Implications. Circulation: Arrhythmia and Electrophysiology. 2026.

DOI: https://doi.org/10.1161/CIRCEP.125.014773

Conduction system pacing and defibrillation: what does ASCEND CSP establish?

Varma and colleagues evaluate a dedicated conduction system pacing defibrillation lead used with a coronary sinus left ventricular lead. We discuss implantation success, capture, electrical performance, defibrillation testing, and ventricular remodeling. Encouraging findings are considered alongside missing paired imaging, background therapy, and the limitations of comparison with a historical matched cohort.

Varma N, et al. Cardiac Resynchronization Therapy Using a Conduction System Pacing Defibrillation Lead in Patients Meeting CRT-D Indications: Six-Month Clinical Outcomes Results From the ASCEND CSP Study. JACC: Clinical Electrophysiology. 2026.

DOI: https://doi.org/10.1016/j.jacep.2026.10.003

Hypertrophic cardiomyopathy: looking beyond left atrial size

Lim and colleagues combine estimated atrial pressure and contractile function to characterize future AF risk. We explain the physiological stages, the increasing incidence of AF, external validation, and the incremental improvement in prediction. Better risk discrimination does not yet establish a stage-based monitoring schedule or treatment threshold.

Lim J, et al. Physiological Left Atrial Staging and the Risk of New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 2026.

DOI: https://doi.org/10.1016/j.jacc.2026.08.014

Chan and Rakowski’s companion editorial examines why stronger atrial contraction may represent compensation against a stiff ventricle rather than preserved atrial health.

Chan RH, Rakowski H. Atrial Cardiomyopathy in Hypertrophic Cardiomyopathy: From Compensation to Atrial Fibrillation. Journal of the American College of Cardiology. 2026.

DOI: https://doi.org/10.1016/j.jacc.2026.09.002

Exercise intensity, new-onset AF, and chronic disease

Wei and colleagues investigate whether vigorous activity contributes information beyond total activity volume. The AF association weakened from approximately 29% to 17% lower relative hazard after additional adjustment. We explain the exposure measure, the apparent plateau, and why these findings do not establish an exercise prescription for established AF or other arrhythmias.

The discussion also examines associations with major cardiovascular events, diabetes, dementia, inflammatory disease, metabolic liver disease, respiratory disease, kidney disease, and mortality. Observational associations remain distinct from proven treatment effects.

Wei J, et al. Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases. European Heart Journal. 2026.

DOI: https://doi.org/10.1093/eurheartj/ehag168

Schwendinger and colleagues’ accompanying editorial places exercise intensity within individual fitness, frailty, and functional capacity.

Schwendinger F, Schmidt-Trucksäss A, Hanssen H. Every step counts and intensity matters: scaling physical activity intensity across chronic diseases. European Heart Journal. 2026.

DOI: https://doi.org/10.1093/eurheartj/ehag288

ALSO COVERED BRIEFLY

Sham controls and patient experience

Bunch and colleagues examine how expectations and additional care affect interpretation of symptomatic benefit after ablation.

Bunch TJ, et al. The indispensable role of sham controls in evaluating interventional therapies: The need for objective rigor in atrial fibrillation ablation. Heart Rhythm. 2026.

DOI: https://doi.org/10.1016/j.hrthm.2026.10.001

Recurrence after pulsed field ablation

Beneyto and colleagues investigate reconnection, durable isolation, and recurrent arrhythmia mechanisms in selected redo patients.

Beneyto M, et al. Characteristics of Recurrent Atrial Arrhythmias and Lesion Assessment Late After Pulsed Field Ablation of Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 2026.

DOI: https://doi.org/10.1161/CIRCEP.125.014506

The PFA learning curve

Yagishita and colleagues examine procedural experience and residual conduction during posterior wall isolation.

Yagishita A, et al. Learning Curve of Pentaspline Pulsed-Field Ablation With Posterior Wall Isolation for Persistent Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2026.

DOI: https://doi...

EP Edge Journal Watch: Cardiac Electrophysiology Research med Niraj Sharma MD FACC FHRS: Cardiac Electrophysiology & Cardiology finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.